http://www.bbc.com/news/world-us-canada-34320413
What a piece of shit that he can say all this with a straight face.
The head of a US pharmaceutical company has defended his company's decision to raise the price of a 62-year-old medication used by Aids patients by over 5,000%.
Turing Pharmaceuticals acquired the rights to Daraprim in August.
CEO Martin Shkreli has said that the company will use the money it makes from sales to research new treatments.
The drug treats toxoplasmosis, a parasitic affliction that affects people with compromised immune systems.
After Turing's acquisition, a dose of Daraprim in the US increased from $13.50 (£8.70) to $750.
. . .
The pill costs about $1 to produce . . .
"These days, modern pharmaceuticals, cancer drugs can cost $100,000 or more, whereas these drugs can cost half a million dollars. Daraprim is still underpriced relative to its peers," [Turing CEO Martin Shkreli] told Bloomberg TV
What a piece of shit that he can say all this with a straight face.